Manufacturer
24 recalls in our database name Calvin Scott & Company, Inc. as the manufacturing or recalling firm.
Of the 24 recalls from Calvin Scott & Company, Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1 (4%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Benzonatate 100mg capsule bottles are mislabeled. Some contain Benzphetamine tablets instead, and vice versa. This medication mix-up affects 10 bottles distributed to one physician in Alpharetta, Georgia.
Calvin Scott & Company recalled Benzphetamine 50mg tablets due to a labeling error where bottles labeled as Benzonatate 100mg capsules contained Benzphetamine 50mg tablets and vice versa. One physician in Alpharetta, Georgia received 13 affected bottles.
Calvin Scott & Company is recalling specific lots of Diethylpropion 25 mg tablets because they were repackaged without supporting stability studies.
Calvin Scott & Company is recalling specific lots of Diethylpropion 75 mg tablets because they were repackaged without supporting stability studies.
Calvin Scott & Company is recalling specific lots of Phentermine 30 mg capsules because they were repackaged without supporting stability studies.
Calvin Scott & Company is recalling specific lots of Phendimetrazine 35mg tablets because they were repackaged in transparent pouches, violating CGMP requirements for light-sensitive drugs.
Calvin Scott & Company is recalling Topiramate 25mg tablets because light-sensitive drugs were repackaged in transparent pouches, violating CGMP standards.
Calvin Scott & Company is recalling specific lots of Phentermine HCL 37.5 mg tablets because they were repackaged in transparent pouches, violating light-sensitivity requirements.
Calvin Scott & Company is recalling Thyroid Neutral Tabs 2 gr because light-sensitive tablets were repackaged in transparent pouches, violating CGMP standards.
Calvin Scott & Company is recalling Hydrochlorothiazide 50mg tablets because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
Calvin Scott & Company is recalling specific lots of Phentermine HCL capsules because light-sensitive products were repackaged in transparent pouches.
Calvin Scott & Co. is recalling Phentermine HCL capsules because light-sensitive products were repackaged in transparent pouches.
Calvin Scott & Company is recalling specific lots of Phentermine HCL tablets because light-sensitive products were repackaged in transparent pouches.
Calvin Scott & Company is recalling Hydrochlorothiazide 25mg tablets because light-sensitive products were repackaged in transparent pouches.
Calvin Scott & Company is recalling Phentermine HCL 30mg capsules because they were repackaged in transparent pouches, exposing the light-sensitive medication to potential degradation.
Calvin Scott & Company is recalling Phentermine HCL 30mg capsules because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
Calvin Scott & Co. is recalling specific lots of Thyroid 1 Grain Tablets because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
Calvin Scott & Company is recalling Phentermine 15mg capsules because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
Calvin Scott & Company is recalling specific lots of Phendimetrazine 35mg tablets because light-sensitive products were repackaged in transparent pouches.
Calvin Scott & Co. is recalling Thyroid 1 Gr tablets because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
Calvin Scott & Co. is recalling Hydrochlorothiazide 25mg tablets because light-sensitive products were repackaged in transparent pouches.
Calvin Scott & Co. is recalling specific lots of Phentermine HCL capsules because they were repackaged in transparent pouches, violating CGMP requirements for light-sensitive drugs.
Calvin Scott & Company is recalling specific lots of Phentermine HCL tablets because they were repackaged in transparent pouches, violating CGMP requirements for light-sensitive drugs.
Calvin Scott & Co. is recalling specific lots of Phendimetrazine capsules because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.